As of 2025-03-15, the EV/EBITDA ratio of Medipharm Labs Corp (LABS.TO) is -1.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LABS.TO's latest enterprise value is 22.85 mil CAD. LABS.TO's TTM EBITDA according to its financial statements is -12.42 mil CAD. Dividing these 2 quantities gives us the above LABS.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 17.0x | 13.6x |
| Forward P/E multiples | 18.5x - 38.5x | 28.5x |
| Fair Price | (0.52) - (0.48) | (0.60) |
| Upside | -715.3% - -661.8% | -805.8% |
| Date | EV/EBITDA |
| 2025-03-06 | -1.67 |
| 2025-03-05 | -1.51 |
| 2025-03-04 | -1.51 |
| 2025-03-03 | -1.51 |
| 2025-02-28 | -1.51 |
| 2025-02-27 | -1.67 |
| 2025-02-26 | -1.34 |
| 2025-02-25 | -1.34 |
| 2025-02-24 | -1.17 |
| 2025-02-21 | -1.17 |
| 2025-02-20 | -1.34 |
| 2025-02-19 | -1.17 |
| 2025-02-18 | -1.17 |
| 2025-02-14 | -1.34 |
| 2025-02-13 | -1.17 |
| 2025-02-12 | -1.17 |
| 2025-02-11 | -1.17 |
| 2025-02-10 | -1.34 |
| 2025-02-07 | -1.34 |
| 2025-02-06 | -1.17 |
| 2025-02-05 | -1.17 |
| 2025-02-04 | -1.17 |
| 2025-02-03 | -1.00 |
| 2025-01-31 | -1.17 |
| 2025-01-30 | -1.17 |
| 2025-01-29 | -1.17 |
| 2025-01-28 | -1.17 |
| 2025-01-27 | -1.17 |
| 2025-01-24 | -1.17 |
| 2025-01-23 | -1.17 |
| 2025-01-22 | -1.17 |
| 2025-01-21 | -1.17 |
| 2025-01-20 | -1.17 |
| 2025-01-17 | -1.34 |
| 2025-01-16 | -1.34 |
| 2025-01-15 | -1.34 |
| 2025-01-14 | -1.17 |
| 2025-01-13 | -1.34 |
| 2025-01-10 | -1.34 |
| 2025-01-09 | -1.51 |
| 2025-01-08 | -1.51 |
| 2025-01-07 | -1.17 |
| 2025-01-06 | -1.17 |
| 2025-01-03 | -1.17 |
| 2025-01-02 | -1.17 |
| 2024-12-31 | -1.00 |
| 2024-12-30 | -1.00 |
| 2024-12-27 | -1.17 |
| 2024-12-24 | -1.17 |
| 2024-12-23 | -1.00 |